Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15

被引:12
作者
TreiberHeld, S
Stewart, DM
Barraclough, HA
Kurman, CC
Nelson, DL
机构
[1] Immunophysiology Section, National Cancer Institute, National Institutes of Health, Bethesda
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1996年 / 80卷 / 01期
基金
美国国家卫生研究院;
关键词
D O I
10.1006/clin.1996.0095
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cytokine interleukin (IL)-15 shares several activities with IL-2. Both cytokines induced expression of cell-surface IL-2R alpha (CD25) on freshly isolated human peripheral blood mononuclear cells (PBMC) in the absence of other exogenous stimuli. They also stimulated the release of soluble IL-2R alpha and induced proliferation of these cells in 1-week cultures in a time-and dose-dependent manner. Recombinant IL-7 could also induce the expression of CD25, although sIL-2R alpha was released at only low levels. In monocyte-depleted PBMC the sIL-2R alpha release was minimal. When isolated T cells or non-T cells were stimulated by rIL-15 or rIL-2, cell surface CD25 was expressed, but released sIL-2R alpha was undetectable. On stimulation with rIL-15, more than 80% of all natural killer cells expressed CD25 and more CD8(br+) lymphocytes were positive for CD25 compared to stimulation by rIL-2. These results may be clinically relevant because several diseases are associated with high serum levels of sIL-2R alpha which may be not only due to IL-2 but also due to IL-15 stimulation. (C) 1996 Academic Press, Inc.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 14 条
[1]  
BROWN T, 1994, CURRENT PROTOCOLS MO
[2]   INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR [J].
CARSON, WE ;
GIRI, JG ;
LINDEMANN, MJ ;
LINETT, ML ;
AHDIEH, M ;
PAXTON, R ;
ANDERSON, D ;
EISENMANN, J ;
GRABSTEIN, K ;
CALIGIURI, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1395-1403
[3]  
DEPPER JM, 1983, J IMMUNOL, V131, P690
[4]   IDENTIFICATION AND CLONING OF A NOVEL IL-15 BINDING-PROTEIN THAT IS STRUCTURALLY RELATED TO THE ALPHA-CHAIN OF THE IL-2 RECEPTOR [J].
GIRI, JG ;
KUMAKI, S ;
AHDIEH, M ;
FRIEND, DJ ;
LOOMIS, A ;
SHANEBECK, K ;
DUBOSE, R ;
COSMAN, D ;
PARK, LS ;
ANDERSON, DM .
EMBO JOURNAL, 1995, 14 (15) :3654-3663
[5]   UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15 [J].
GIRI, JG ;
AHDIEH, M ;
EISENMAN, J ;
SHANEBECK, K ;
GRABSTEIN, K ;
KUMAKI, S ;
NAMEN, A ;
PARK, LS ;
COSMAN, D ;
ANDERSON, D .
EMBO JOURNAL, 1994, 13 (12) :2822-2830
[6]   CLONING OF A T-CELL GROWTH-FACTOR THAT INTERACTS WITH THE BETA-CHAIN OF THE INTERLEUKIN-2 RECEPTOR [J].
GRABSTEIN, KH ;
EISENMAN, J ;
SHANEBECK, K ;
RAUCH, C ;
SRINIVASAN, S ;
FUNG, V ;
BEERS, C ;
RICHARDSON, J ;
SCHOENBORN, MA ;
AHDIEH, M ;
JOHNSON, L ;
ALDERSON, MR ;
WATSON, JD ;
ANDERSON, DM ;
GIRI, JG .
SCIENCE, 1994, 264 (5161) :965-968
[7]  
KEDAR E, 1988, NAT IMMUN CELL GROW, V7, P13
[8]   MOLECULAR-CLONING AND EXPRESSION OF CDNAS FOR THE HUMAN INTERLEUKIN-2 RECEPTOR [J].
LEONARD, WJ ;
DEPPER, JM ;
CRABTREE, GR ;
RUDIKOFF, S ;
PUMPHREY, J ;
ROBB, RJ ;
KRONKE, M ;
SVETLIK, PB ;
PEFFER, NJ ;
WALDMANN, TA ;
GREENE, WC .
NATURE, 1984, 311 (5987) :626-631
[9]   METHODOLOGICAL STUDY OF E-ROSETTE FORMATION USING AET-TREATED SHEEP RED BLOOD-CELLS [J].
MADSEN, M ;
JOHNSEN, HE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1979, 27 (01) :61-74
[10]   T-CELL GROWTH-FACTOR RECEPTORS - QUANTITATION, SPECIFICITY, AND BIOLOGICAL RELEVANCE [J].
ROBB, RJ ;
MUNCK, A ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (05) :1455-1474